ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Low Molecular Weight Heparin API Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-19Z15375
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Low Molecular Weight Heparin API Market Insights Forecast to 2029
BUY CHAPTERS

Global Low Molecular Weight Heparin API Market Research Report 2025

Code: QYRE-Auto-19Z15375
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing King-friend
Hebei Changshan
NanJing Nanda Pharmaceutical

Low Molecular Weight Heparin API Market Size

The global market for Low Molecular Weight Heparin API was valued at US$ 730 million in the year 2024 and is projected to reach a revised size of US$ 1391 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Low Molecular Weight Heparin API Market

Low Molecular Weight Heparin API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Low Molecular Weight Heparin API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.
The Low Molecular Weight Heparin (LMWH) API market plays a crucial role in the global pharmaceutical industry due to the widespread use of LMWHs in the prevention and treatment of blood clot-related disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH APIs are preferred in clinical settings for their favorable pharmacological properties, including better bioavailability, longer half-life, and reduced risk of side effects compared to unfractionated heparin. The increasing prevalence of cardiovascular diseases and venous thromboembolism, aging populations, and a rise in surgical procedures worldwide have significantly driven demand for LMWH-based therapies.
The North American and European markets lead in demand due to a high prevalence of thrombosis-related conditions and advanced healthcare infrastructure. Asia-Pacific is emerging as a growth market, driven by increased healthcare spending and the rise of generics.
Low Molecular Weight Heparin API segment market, the Enoxaparin Sodium holds an important share, and it is expected to reach a value of US$ 1,258.82 million by 2030, at a CAGR of 12.46% during 2024 and 2030.
The global key companies of Low Molecular Weight Heparin API include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, and Qingdao Jiulong Biopharmaceutical, etc. In 2023, the global five largest players hold a share approximately 72.91% in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin API.
The Low Molecular Weight Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Low Molecular Weight Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low Molecular Weight Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Low Molecular Weight Heparin API Market Report

Report Metric Details
Report Name Low Molecular Weight Heparin API Market
Accounted market size in year US$ 730 million
Forecasted market size in 2031 US$ 1391 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan, Hubei Enoray Biopharmaceutical, Nanjing Nanda Pharmaceutical, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Low Molecular Weight Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Low Molecular Weight Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Low Molecular Weight Heparin API Market growing?

Ans: The Low Molecular Weight Heparin API Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Low Molecular Weight Heparin API Market size in 2031?

Ans: The Low Molecular Weight Heparin API Market size in 2031 will be US$ 1391 million.

Who are the main players in the Low Molecular Weight Heparin API Market report?

Ans: The main players in the Low Molecular Weight Heparin API Market are Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan, Hubei Enoray Biopharmaceutical, Nanjing Nanda Pharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Low Molecular Weight Heparin API Market report?

Ans: The Applications covered in the Low Molecular Weight Heparin API Market report are Enoxaparin Sodium, Nadroparin Calcium, Dalteparin Sodium, Tinzaparin Sodium, Parnaparin Sodium

What are the Type segmentation covered in the Low Molecular Weight Heparin API Market report?

Ans: The Types covered in the Low Molecular Weight Heparin API Market report are Low Molecular Weight Heparin Sodium, Low Molecular Weight Heparin Calcium

Recommended Reports

Heparin API Markets

Anticoagulant Products

Heparin Supply Chain

1 Low Molecular Weight Heparin API Market Overview
1.1 Product Definition
1.2 Low Molecular Weight Heparin API by Type
1.2.1 Global Low Molecular Weight Heparin API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Low Molecular Weight Heparin Sodium
1.2.3 Low Molecular Weight Heparin Calcium
1.3 Low Molecular Weight Heparin API by Application
1.3.1 Global Low Molecular Weight Heparin API Market Value by Application (2024 VS 2031)
1.3.2 Enoxaparin Sodium
1.3.3 Nadroparin Calcium
1.3.4 Dalteparin Sodium
1.3.5 Tinzaparin Sodium
1.3.6 Parnaparin Sodium
1.4 Global Low Molecular Weight Heparin API Market Size Estimates and Forecasts
1.4.1 Global Low Molecular Weight Heparin API Revenue 2020-2031
1.4.2 Global Low Molecular Weight Heparin API Sales 2020-2031
1.4.3 Global Low Molecular Weight Heparin API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Low Molecular Weight Heparin API Market Competition by Manufacturers
2.1 Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Low Molecular Weight Heparin API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Low Molecular Weight Heparin API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Low Molecular Weight Heparin API, Product Type & Application
2.7 Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Enter into This Industry
2.8 Global Low Molecular Weight Heparin API Market Competitive Situation and Trends
2.8.1 Global Low Molecular Weight Heparin API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Low Molecular Weight Heparin API Players Market Share by Revenue
2.8.3 Global Low Molecular Weight Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Low Molecular Weight Heparin API Market Scenario by Region
3.1 Global Low Molecular Weight Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Low Molecular Weight Heparin API Sales by Region: 2020-2031
3.2.1 Global Low Molecular Weight Heparin API Sales by Region: 2020-2025
3.2.2 Global Low Molecular Weight Heparin API Sales by Region: 2026-2031
3.3 Global Low Molecular Weight Heparin API Revenue by Region: 2020-2031
3.3.1 Global Low Molecular Weight Heparin API Revenue by Region: 2020-2025
3.3.2 Global Low Molecular Weight Heparin API Revenue by Region: 2026-2031
3.4 North America Low Molecular Weight Heparin API Market Facts & Figures by Country
3.4.1 North America Low Molecular Weight Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Low Molecular Weight Heparin API Sales by Country (2020-2031)
3.4.3 North America Low Molecular Weight Heparin API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Low Molecular Weight Heparin API Market Facts & Figures by Country
3.5.1 Europe Low Molecular Weight Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Low Molecular Weight Heparin API Sales by Country (2020-2031)
3.5.3 Europe Low Molecular Weight Heparin API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Low Molecular Weight Heparin API Market Facts & Figures by Region
3.6.1 Asia Pacific Low Molecular Weight Heparin API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Low Molecular Weight Heparin API Sales by Region (2020-2031)
3.6.3 Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Low Molecular Weight Heparin API Market Facts & Figures by Country
3.7.1 Latin America Low Molecular Weight Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Low Molecular Weight Heparin API Sales by Country (2020-2031)
3.7.3 Latin America Low Molecular Weight Heparin API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Low Molecular Weight Heparin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Low Molecular Weight Heparin API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Low Molecular Weight Heparin API Sales by Type (2020-2031)
4.1.1 Global Low Molecular Weight Heparin API Sales by Type (2020-2025)
4.1.2 Global Low Molecular Weight Heparin API Sales by Type (2026-2031)
4.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Type (2020-2031)
4.2 Global Low Molecular Weight Heparin API Revenue by Type (2020-2031)
4.2.1 Global Low Molecular Weight Heparin API Revenue by Type (2020-2025)
4.2.2 Global Low Molecular Weight Heparin API Revenue by Type (2026-2031)
4.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Type (2020-2031)
4.3 Global Low Molecular Weight Heparin API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Low Molecular Weight Heparin API Sales by Application (2020-2031)
5.1.1 Global Low Molecular Weight Heparin API Sales by Application (2020-2025)
5.1.2 Global Low Molecular Weight Heparin API Sales by Application (2026-2031)
5.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Application (2020-2031)
5.2 Global Low Molecular Weight Heparin API Revenue by Application (2020-2031)
5.2.1 Global Low Molecular Weight Heparin API Revenue by Application (2020-2025)
5.2.2 Global Low Molecular Weight Heparin API Revenue by Application (2026-2031)
5.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Application (2020-2031)
5.3 Global Low Molecular Weight Heparin API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Yantai Dongcheng Pharmaceutical
6.1.1 Yantai Dongcheng Pharmaceutical Company Information
6.1.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.1.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.2 Shenzhen Hepalink Pharmaceutical
6.2.1 Shenzhen Hepalink Pharmaceutical Company Information
6.2.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.2.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.3 Nanjing King-friend
6.3.1 Nanjing King-friend Company Information
6.3.2 Nanjing King-friend Description and Business Overview
6.3.3 Nanjing King-friend Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing King-friend Low Molecular Weight Heparin API Product Portfolio
6.3.5 Nanjing King-friend Recent Developments/Updates
6.4 Changzhou Qianhong Biopharma
6.4.1 Changzhou Qianhong Biopharma Company Information
6.4.2 Changzhou Qianhong Biopharma Description and Business Overview
6.4.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product Portfolio
6.4.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.5 Qingdao Jiulong Biopharmaceutical
6.5.1 Qingdao Jiulong Biopharmaceutical Company Information
6.5.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.5.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.5.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Dongying Tiandong Pharmaceutical Company Information
6.6.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.7 Yino Pharma
6.7.1 Yino Pharma Company Information
6.7.2 Yino Pharma Description and Business Overview
6.7.3 Yino Pharma Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yino Pharma Low Molecular Weight Heparin API Product Portfolio
6.7.5 Yino Pharma Recent Developments/Updates
6.8 Opocrin
6.8.1 Opocrin Company Information
6.8.2 Opocrin Description and Business Overview
6.8.3 Opocrin Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Opocrin Low Molecular Weight Heparin API Product Portfolio
6.8.5 Opocrin Recent Developments/Updates
6.9 Hebei Changshan
6.9.1 Hebei Changshan Company Information
6.9.2 Hebei Changshan Description and Business Overview
6.9.3 Hebei Changshan Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hebei Changshan Low Molecular Weight Heparin API Product Portfolio
6.9.5 Hebei Changshan Recent Developments/Updates
6.10 Hubei Enoray Biopharmaceutical
6.10.1 Hubei Enoray Biopharmaceutical Company Information
6.10.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.10.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.10.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.11 Nanjing Nanda Pharmaceutical
6.11.1 Nanjing Nanda Pharmaceutical Company Information
6.11.2 Nanjing Nanda Pharmaceutical Description and Business Overview
6.11.3 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.11.5 Nanjing Nanda Pharmaceutical Recent Developments/Updates
6.12 Cisen Pharmaceutical
6.12.1 Cisen Pharmaceutical Company Information
6.12.2 Cisen Pharmaceutical Description and Business Overview
6.12.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.12.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Low Molecular Weight Heparin API Industry Chain Analysis
7.2 Low Molecular Weight Heparin API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Low Molecular Weight Heparin API Production Mode & Process Analysis
7.4 Low Molecular Weight Heparin API Sales and Marketing
7.4.1 Low Molecular Weight Heparin API Sales Channels
7.4.2 Low Molecular Weight Heparin API Distributors
7.5 Low Molecular Weight Heparin API Customer Analysis
8 Low Molecular Weight Heparin API Market Dynamics
8.1 Low Molecular Weight Heparin API Industry Trends
8.2 Low Molecular Weight Heparin API Market Drivers
8.3 Low Molecular Weight Heparin API Market Challenges
8.4 Low Molecular Weight Heparin API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing King-friend
Hebei Changshan
NanJing Nanda Pharmaceutical
List of Tables
 Table 1. Global Low Molecular Weight Heparin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Low Molecular Weight Heparin API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Low Molecular Weight Heparin API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Low Molecular Weight Heparin API Sales (Billion Units) of Key Manufacturers (2020-2025)
 Table 5. Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Low Molecular Weight Heparin API Average Price (US$/Billion Untis) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Low Molecular Weight Heparin API, Product Type & Application
 Table 12. Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Low Molecular Weight Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Low Molecular Weight Heparin API Sales by Region (2020-2025) & (Billion Units)
 Table 18. Global Low Molecular Weight Heparin API Sales Market Share by Region (2020-2025)
 Table 19. Global Low Molecular Weight Heparin API Sales by Region (2026-2031) & (Billion Units)
 Table 20. Global Low Molecular Weight Heparin API Sales Market Share by Region (2026-2031)
 Table 21. Global Low Molecular Weight Heparin API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2020-2025)
 Table 23. Global Low Molecular Weight Heparin API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2026-2031)
 Table 25. North America Low Molecular Weight Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Low Molecular Weight Heparin API Sales by Country (2020-2025) & (Billion Units)
 Table 27. North America Low Molecular Weight Heparin API Sales by Country (2026-2031) & (Billion Units)
 Table 28. North America Low Molecular Weight Heparin API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Low Molecular Weight Heparin API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Low Molecular Weight Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Low Molecular Weight Heparin API Sales by Country (2020-2025) & (Billion Units)
 Table 32. Europe Low Molecular Weight Heparin API Sales by Country (2026-2031) & (Billion Units)
 Table 33. Europe Low Molecular Weight Heparin API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Low Molecular Weight Heparin API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Low Molecular Weight Heparin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Low Molecular Weight Heparin API Sales by Region (2020-2025) & (Billion Units)
 Table 37. Asia Pacific Low Molecular Weight Heparin API Sales by Region (2026-2031) & (Billion Units)
 Table 38. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Low Molecular Weight Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Low Molecular Weight Heparin API Sales by Country (2020-2025) & (Billion Units)
 Table 42. Latin America Low Molecular Weight Heparin API Sales by Country (2026-2031) & (Billion Units)
 Table 43. Latin America Low Molecular Weight Heparin API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Low Molecular Weight Heparin API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2020-2025) & (Billion Units)
 Table 47. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2026-2031) & (Billion Units)
 Table 48. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2020-2025)
 Table 51. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2026-2031)
 Table 52. Global Low Molecular Weight Heparin API Sales Market Share by Type (2020-2025)
 Table 53. Global Low Molecular Weight Heparin API Sales Market Share by Type (2026-2031)
 Table 54. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2020-2025)
 Table 57. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2026-2031)
 Table 58. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2020-2025)
 Table 59. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2026-2031)
 Table 60. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2020-2025)
 Table 61. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2026-2031)
 Table 62. Global Low Molecular Weight Heparin API Sales Market Share by Application (2020-2025)
 Table 63. Global Low Molecular Weight Heparin API Sales Market Share by Application (2026-2031)
 Table 64. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2020-2025)
 Table 67. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2026-2031)
 Table 68. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2020-2025)
 Table 69. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2026-2031)
 Table 70. Yantai Dongcheng Pharmaceutical Company Information
 Table 71. Yantai Dongcheng Pharmaceutical Description and Business Overview
 Table 72. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 73. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product
 Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
 Table 75. Shenzhen Hepalink Pharmaceutical Company Information
 Table 76. Shenzhen Hepalink Pharmaceutical Description and Business Overview
 Table 77. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 78. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product
 Table 79. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
 Table 80. Nanjing King-friend Company Information
 Table 81. Nanjing King-friend Description and Business Overview
 Table 82. Nanjing King-friend Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 83. Nanjing King-friend Low Molecular Weight Heparin API Product
 Table 84. Nanjing King-friend Recent Developments/Updates
 Table 85. Changzhou Qianhong Biopharma Company Information
 Table 86. Changzhou Qianhong Biopharma Description and Business Overview
 Table 87. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 88. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product
 Table 89. Changzhou Qianhong Biopharma Recent Developments/Updates
 Table 90. Qingdao Jiulong Biopharmaceutical Company Information
 Table 91. Qingdao Jiulong Biopharmaceutical Description and Business Overview
 Table 92. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 93. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product
 Table 94. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
 Table 95. Dongying Tiandong Pharmaceutical Company Information
 Table 96. Dongying Tiandong Pharmaceutical Description and Business Overview
 Table 97. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 98. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product
 Table 99. Dongying Tiandong Pharmaceutical Recent Developments/Updates
 Table 100. Yino Pharma Company Information
 Table 101. Yino Pharma Description and Business Overview
 Table 102. Yino Pharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 103. Yino Pharma Low Molecular Weight Heparin API Product
 Table 104. Yino Pharma Recent Developments/Updates
 Table 105. Opocrin Company Information
 Table 106. Opocrin Description and Business Overview
 Table 107. Opocrin Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 108. Opocrin Low Molecular Weight Heparin API Product
 Table 109. Opocrin Recent Developments/Updates
 Table 110. Hebei Changshan Company Information
 Table 111. Hebei Changshan Description and Business Overview
 Table 112. Hebei Changshan Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 113. Hebei Changshan Low Molecular Weight Heparin API Product
 Table 114. Hebei Changshan Recent Developments/Updates
 Table 115. Hubei Enoray Biopharmaceutical Company Information
 Table 116. Hubei Enoray Biopharmaceutical Description and Business Overview
 Table 117. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 118. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product
 Table 119. Hubei Enoray Biopharmaceutical Recent Developments/Updates
 Table 120. Nanjing Nanda Pharmaceutical Company Information
 Table 121. Nanjing Nanda Pharmaceutical Description and Business Overview
 Table 122. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 123. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product
 Table 124. Nanjing Nanda Pharmaceutical Recent Developments/Updates
 Table 125. Cisen Pharmaceutical Company Information
 Table 126. Cisen Pharmaceutical Description and Business Overview
 Table 127. Cisen Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis) and Gross Margin (2020-2025)
 Table 128. Cisen Pharmaceutical Low Molecular Weight Heparin API Product
 Table 129. Cisen Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Low Molecular Weight Heparin API Distributors List
 Table 133. Low Molecular Weight Heparin API Customers List
 Table 134. Low Molecular Weight Heparin API Market Trends
 Table 135. Low Molecular Weight Heparin API Market Drivers
 Table 136. Low Molecular Weight Heparin API Market Challenges
 Table 137. Low Molecular Weight Heparin API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Low Molecular Weight Heparin API
 Figure 2. Global Low Molecular Weight Heparin API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Low Molecular Weight Heparin API Market Share by Type: 2024 & 2031
 Figure 4. Low Molecular Weight Heparin Sodium Product Picture
 Figure 5. Low Molecular Weight Heparin Calcium Product Picture
 Figure 6. Global Low Molecular Weight Heparin API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Low Molecular Weight Heparin API Market Share by Application: 2024 & 2031
 Figure 8. Enoxaparin Sodium
 Figure 9. Nadroparin Calcium
 Figure 10. Dalteparin Sodium
 Figure 11. Tinzaparin Sodium
 Figure 12. Parnaparin Sodium
 Figure 13. Global Low Molecular Weight Heparin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Low Molecular Weight Heparin API Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Low Molecular Weight Heparin API Sales (2020-2031) & (Billion Units)
 Figure 16. Global Low Molecular Weight Heparin API Average Price (US$/Billion Untis) & (2020-2031)
 Figure 17. Low Molecular Weight Heparin API Report Years Considered
 Figure 18. Low Molecular Weight Heparin API Sales Share by Manufacturers in 2024
 Figure 19. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Low Molecular Weight Heparin API Players: Market Share by Revenue in Low Molecular Weight Heparin API in 2024
 Figure 21. Low Molecular Weight Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Low Molecular Weight Heparin API Sales Market Share by Country (2020-2031)
 Figure 24. North America Low Molecular Weight Heparin API Revenue Market Share by Country (2020-2031)
 Figure 25. United States Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Low Molecular Weight Heparin API Sales Market Share by Country (2020-2031)
 Figure 28. Europe Low Molecular Weight Heparin API Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Low Molecular Weight Heparin API Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Low Molecular Weight Heparin API Revenue Market Share by Region (2020-2031)
 Figure 36. China Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Low Molecular Weight Heparin API Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Low Molecular Weight Heparin API Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Low Molecular Weight Heparin API Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Low Molecular Weight Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Low Molecular Weight Heparin API by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Low Molecular Weight Heparin API by Type (2020-2031)
 Figure 56. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Low Molecular Weight Heparin API by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Low Molecular Weight Heparin API by Application (2020-2031)
 Figure 59. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2020-2031)
 Figure 60. Low Molecular Weight Heparin API Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Low Molecular Weight Heparin Injection Market Research Report 2024
Global LMWH Products Market Insights Forecast to 2030
Global Low Molecular Weight Heparin Market Research Report 2025
Global Low Molecular Weight Heparin Sodium Market Insights Forecast to 2030
Low Molecular Weight Heparin LMWHs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enoxaparin API Market Research Report 2025
Global Porcine Heparin APIs Market Research Report 2024
Global Lab synthesized Heparin Market Research Report 2024
Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nadroparin Calcium Market Research Report 2024
Heparin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Anticoagulants Market Research Report 2025
Global Ultra low Molecular Weight Heparin ULMWH Market Research Report 2024
Heparin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Crude Unfractionated Heparin UFH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin Low Molecular Weight Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Market Insights Forecast to 2030
Global Heparin Sodium Active Pharmaceutical Ingredient Market Research Report 2024
Global Crude Heparin Market Research Report 2024
Medical Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions